Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,850 | 8 | 57.3% |
| Food and Beverage | $5,813 | 230 | 24.1% |
| Consulting Fee | $2,250 | 1 | 9.3% |
| Travel and Lodging | $2,206 | 2 | 9.1% |
| Education | $37.62 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $17,023 | 23 | $0 (2024) |
| Janssen Biotech, Inc. | $2,616 | 17 | $0 (2024) |
| Amgen Inc. | $1,422 | 105 | $0 (2024) |
| PFIZER INC. | $568.15 | 30 | $0 (2024) |
| ABBVIE INC. | $542.69 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $435.53 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $318.98 | 10 | $0 (2024) |
| Lilly USA, LLC | $185.37 | 6 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $179.02 | 7 | $0 (2024) |
| UCB, Inc. | $152.12 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,136 | 45 | Amgen Inc. ($386.57) |
| 2023 | $1,151 | 47 | Amgen Inc. ($320.98) |
| 2022 | $918.19 | 33 | Amgen Inc. ($193.71) |
| 2021 | $690.27 | 45 | Amgen Inc. ($353.04) |
| 2020 | $2,523 | 20 | Janssen Biotech, Inc. ($2,325) |
| 2019 | $847.24 | 27 | GlaxoSmithKline, LLC. ($180.43) |
| 2018 | $1,676 | 8 | Janssen Scientific Affairs, LLC ($1,500) |
| 2017 | $15,215 | 19 | Janssen Scientific Affairs, LLC ($15,028) |
All Payment Transactions
244 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: Inflammation | ||||||
| 12/20/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $36.59 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/08/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $118.73 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Immunology | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: Inflammation | ||||||
| 09/20/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/28/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Inflammation | ||||||
| 08/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Endocrinology | ||||||
| 08/09/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/01/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Inflammation | ||||||
| 07/17/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Inflammation | ||||||
| 07/11/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Biosimilars | ||||||
| 07/10/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: IMMUNOLOGY | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 06/20/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/20/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/13/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $5.89 | General |
| Category: Inflammation | ||||||
| 06/12/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $99.44 | General |
| Category: Immunology | ||||||
| 05/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.63 | General |
| 05/16/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 384 | 51,801 | $619,594 | $290,989 |
| 2022 | 16 | 531 | 55,740 | $954,437 | $348,096 |
| 2021 | 19 | 858 | 9,565 | $1.2M | $454,326 |
| 2020 | 14 | 493 | 2,501 | $215,973 | $73,481 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 13 | 50,810 | $400,880 | $234,976 | 58.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 161 | 274 | $141,110 | $35,088 | 24.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 53 | 145 | $26,825 | $7,389 | 27.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 16 | 61 | $23,058 | $6,334 | 27.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $8,216 | $2,219 | 27.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 16 | 83 | $6,723 | $1,856 | 27.6% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 33 | 165 | $3,300 | $1,105 | 33.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 15 | $3,273 | $872.84 | 26.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 58 | $870.00 | $487.20 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $4,195 | $344.25 | 8.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 17 | $697.00 | $191.76 | 27.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 18 | 149 | $447.00 | $126.30 | 28.3% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2022 | 12 | 51,720 | $413,760 | $235,661 | 57.0% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 12 | 2,625 | $322,875 | $54,474 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 174 | 322 | $109,802 | $27,591 | 25.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 57 | 192 | $34,944 | $10,323 | 29.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 23 | 66 | $24,354 | $6,686 | 27.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 36 | $17,316 | $4,883 | 28.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 23 | 84 | $6,552 | $1,862 | 28.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $6,490 | $1,790 | 27.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 18 | 19 | $6,479 | $1,467 | 22.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 17 | 22 | $4,900 | $1,301 | 26.5% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2022 | 26 | 130 | $2,600 | $597.39 | 23.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 24 | 39 | $1,482 | $439.15 | 29.6% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 14 | 29 | $1,204 | $377.78 | 31.4% |
About Dr. Rebecca Muntean, M.D
Dr. Rebecca Muntean, M.D is a Rheumatology healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1003071598.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rebecca Muntean, M.D has received a total of $24,156 in payments from pharmaceutical and medical device companies, with $1,136 received in 2024. These payments were reported across 244 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,850).
As a Medicare-enrolled provider, Muntean has provided services to 2,266 Medicare beneficiaries, totaling 119,607 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology
- Location Spokane, WA
- Active Since 07/23/2008
- Last Updated 03/01/2021
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1003071598
Products in Payments
- SIMPONI ARIA (Biological) $9,577
- STELARA (Biological) $7,202
- TREMFYA (Drug) $2,757
- Enbrel (Biological) $1,065
- XELJANZ (Drug) $568.15
- RINVOQ (Biological) $367.34
- SAPHNELO (Biological) $347.80
- BENLYSTA (Biological) $263.35
- TALTZ (Drug) $169.64
- PURIFIED CORTROPHIN GEL (Drug) $169.29
- KRYSTEXXA (Biological) $150.38
- NATPARA (PARATHYROID HORMONE) (Drug) $124.68
- COSENTYX (Biological) $116.60
- Humira (Biological) $100.65
- SIMPONI (Biological) $95.45
- TAVNEOS (Drug) $82.66
- Rituxan (Biological) $81.64
- Rinvoq (Biological) $74.70
- AVSOLA (Biological) $72.57
- Otezla (Drug) $62.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Spokane
Eric Mueller, M.d, M.D
Rheumatology — Payments: $66,481
Dr. Michael Coan, D.o, D.O
Rheumatology — Payments: $10,071
Dr. Sean Lasalle, Md, MD
Rheumatology — Payments: $9,964
Penny Sczenski, Agpcnp-Bc, AGPCNP-BC
Rheumatology — Payments: $2,792
Catherine Lee, Md, MD
Rheumatology — Payments: $1,457
Lauren Johnson, M.d, M.D
Rheumatology — Payments: $383.30